Global Injectable Fertility Medications Market Growth 2024-2030

Global Injectable Fertility Medications Market Growth 2024-2030

Injectable fertility medications are pharmaceutical drugs administered through injections to assist individuals or couples in overcoming fertility challenges. These medications, often used in assisted reproductive technologies like in vitro fertilization (IVF), aim to stimulate the ovaries to produce multiple eggs or regulate the reproductive cycle. Injectable fertility drugs commonly include gonadotropins, such as follicle-stimulating hormone (FSH) and luteinizing hormone (LH), as well as human chorionic gonadotropin (hCG). These medications play a crucial role in controlling and optimizing the reproductive process, enhancing the chances of successful conception for individuals facing fertility issues.

The global Injectable Fertility Medications market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Injectable Fertility Medications Industry Forecast” looks at past sales and reviews total world Injectable Fertility Medications sales in 2023, providing a comprehensive analysis by region and market sector of projected Injectable Fertility Medications sales for 2024 through 2030. With Injectable Fertility Medications sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Injectable Fertility Medications industry.

This Insight Report provides a comprehensive analysis of the global Injectable Fertility Medications landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Injectable Fertility Medications portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Injectable Fertility Medications market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Injectable Fertility Medications and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Injectable Fertility Medications.

The fertility preservation and infertility treatment market has witnessed significant growth in recent years, driven by factors such as increasing infertility rates, delayed pregnancies, advancements in assisted reproductive technologies (ART), and growing awareness. Fertility preservation technologies, including egg freezing and sperm banking, have gained popularity among individuals seeking to preserve their reproductive potential. In the infertility treatment segment, in vitro fertilization (IVF), intrauterine insemination (IUI), and other ART procedures have become mainstream options. Future developments are anticipated in areas such as personalized medicine, gene editing technologies, and improved success rates in ART procedures. The market is likely to see ongoing advancements, innovations, and collaborations aimed at addressing infertility challenges and expanding the range of options available to individuals and couples.

This report presents a comprehensive overview, market shares, and growth opportunities of Injectable Fertility Medications market by product type, application, key manufacturers and key regions and countries.

Segmentation by type
Follicle Stimulating Hormone (FSH)
Luteinizing Hormone (LH)
Human Chorionic Gonadotropin (hCG)
Others

Segmentation by application
IVF and Embryo Transfer
Infertility Treatment

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Gonal-F (Merck)
Follistim (Organon)
Bravelle (Ferring)
Menopur (Ferring)
Fostimon (IBSA)
Puregon (Organon)
BEMFOLA (Gedeon Richter)
Novarel (Ferring)
Ovidrel (Merck)
Synarel (Pfizer Medical)
Follitrope (LG Chem)
Profasi (Serum Institute Of India)
Livzon
GenSci

Key Questions Addressed in this Report

What is the 10-year outlook for the global Injectable Fertility Medications market?

What factors are driving Injectable Fertility Medications market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Injectable Fertility Medications market opportunities vary by end market size?

How does Injectable Fertility Medications break out type, application?

Please note: The report will take approximately 2 business days to prepare and deliver.